Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Rubenstein

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Blood Advances|April 10, 2024
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101Tracy T Batchelor, Sharmila Giri, Amy S Ruppert, et al.
Blood Advances|July 11, 2018
Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphomaJames L Rubenstein, Huimin Geng, Eleanor J Fraser, et al.
Neuro-Oncology|September 1, 2016
Long-term survival in AIDS-related primary central nervous system lymphomaNeel K Gupta, Amber Nolan, Antonio Omuro, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS)Jackson T Bowers, Anjanaa Vijayanarayanan, Natalie Gill, et al.
Neuro-Oncology|April 10, 2024
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO reviewLakshmi Nayak, Chetan Bettegowda, Florian Scherer, et al.
Neuro-Oncology|February 9, 2021
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)Ramon F Barajas, Letterio S Politi, Nicoletta Anzalone, et al.
Blood Advances|February 14, 2022
A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcomeEkin Güney, Calixto-Hope G Lucas, Zhongxia Qi, et al.
Blood Advances|March 10, 2023
Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNSEkin Guney, Calixto-Hope G Lucas, Kunwar Singh, et al.
Open Biology|December 17, 2024
Small molecule protein assembly modulators with pan-cancer therapeutic efficacyAnuradha F Lingappa, Olayemi Akintunde, Erin Samueli, et al.
Leukemia & Lymphoma|March 24, 2023
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohortPrashasti Agrawal, Kevin A David, Zhengming Chen, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Blood Advances|April 10, 2024
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101Tracy T Batchelor, Sharmila Giri, Amy S Ruppert, et al.
Blood Advances|July 11, 2018
Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphomaJames L Rubenstein, Huimin Geng, Eleanor J Fraser, et al.
Neuro-Oncology|September 1, 2016
Long-term survival in AIDS-related primary central nervous system lymphomaNeel K Gupta, Amber Nolan, Antonio Omuro, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS)Jackson T Bowers, Anjanaa Vijayanarayanan, Natalie Gill, et al.
Neuro-Oncology|April 10, 2024
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO reviewLakshmi Nayak, Chetan Bettegowda, Florian Scherer, et al.
Neuro-Oncology|February 9, 2021
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)Ramon F Barajas, Letterio S Politi, Nicoletta Anzalone, et al.
Blood Advances|February 14, 2022
A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcomeEkin Güney, Calixto-Hope G Lucas, Zhongxia Qi, et al.
Blood Advances|March 10, 2023
Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNSEkin Guney, Calixto-Hope G Lucas, Kunwar Singh, et al.
Open Biology|December 17, 2024
Small molecule protein assembly modulators with pan-cancer therapeutic efficacyAnuradha F Lingappa, Olayemi Akintunde, Erin Samueli, et al.
Leukemia & Lymphoma|March 24, 2023
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohortPrashasti Agrawal, Kevin A David, Zhengming Chen, et al.
Pageof 6